- Reproductive/Sexual Health
- Cardiovascular
- CNS/Neurological
- Dermatology
- Diagnostics
- Gastrointestinal
- Gene/Cell Therapy
- Immunology
- Infectious Diseases
- Inflammation
- Metabolic Diseases
- Multiple Therapeutics
- Oncology
- Ophthalmology
- Pain Management
- Platform for Therapeutics
- Regenerative Medicine
- Respiratory
- Tools/Drug Development Support Tech
12:00 PM
-
300 mins
1:30 PM
-
240 minsOn the afternoon of October 16th, BIO will present the first BIO Seed-Stage Spotlight on Tech Transfer, featuring more than two dozen exciting early-stage companies giving brief pitches and getting in ...
5:30 PM
-
60 minsAttendees of the BIO Seed-Stage Spotlight on Tech Transfer are invited to join us for a reception to cap off the day of presentations.
6:30 AM
-
630 mins
7:30 AM
-
600 mins
9:00 AM
-
Franciscan B/C/D180 mins
Attend 13-minute presentations across several therapeutic areas.
9:45 AM
-
Franciscan C15 mins
- Oncology
Diakonos Oncology is a clinical-stage biotechnology company, developing a novel "Double-Loaded" Dendritic Cell Vaccine (DCV) for the treatment of Glioblastoma Multiforme (GBM) as well as other difficu ... -
Franciscan D15 mins
- Diagnostics
Company Description: Craif has developed a miRNA platform and proprietary sampling technology that allows the capture of lower expression RNA in order to develop assays that can accurately predict a p ...
10:00 AM
-
Imperial Ballroom50 minsWith bank failures and volatile markets this year, it is more important than ever for early-stage companies to demonstrate their distinct strengths as investors evaluate their priorities. Attend this ...
-
Franciscan C15 mins
- Oncology
Panavance Therapeutics Inc. is a privately-held, clinical-stage pharmaceutical company developing a novel oncology platform focused on improving the outcomes and quality of life for patients. Panavanc ... -
Franciscan D15 mins
- Diagnostics
Company Description: Imagion Biosystems, Ltd. (ASX: IBX) is pioneering molecularly targeted MRI Contrast Agents with its MagSense® technology - a new functional imaging product line that holds the pro ... -
Franciscan B15 mins
- Dermatology
Company Description: NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative power of nitric oxide (NO) to heal chronic wounds. NOxy ...
10:15 AM
-
Franciscan D15 mins
- Regenerative Medicine
Biotech developing mRNA therapeutics to combat aging and age-related disease -
Franciscan C15 mins
- Oncology
Pacylex Pharmaceuticals is a Canadian oncology company in Phase 2 with a highly differentiated cancer therapy, zelenirstat (PCLX-001), a first in class, once-per-day oral medication that completely re ... -
Franciscan B15 mins
- Oncology
Company Description: Estrigenix Therapeutics is preclinical pharmaceutical development company pioneering therapies to improving women's health. Estrigenix was formed as a spinout of collaborative res ...
10:30 AM
-
Franciscan C15 mins
- Oncology
Osmol is an IND-stage biopharma company based in New Haven, CT, developing technology licensed from Yale School of Medicine to address chemotherapy induced peripheral neuropathy (CIPN). CIPN is a sign ... -
Franciscan B15 mins
- Oncology
ZWI Therapeutics is a biotechnology company developing novel protein therapeutics linked to a novel polymer. The company’s proprietary polymer technology reduces the immunogenicity of therapeutic prot ... -
Franciscan D15 mins
- Oncology
Aptah's molecule is the first and only compound that assures accurate RNA processing of multiple proteins. It works as a template for overall RNA quality control, altering the fate of diseased cells w ...
10:45 AM
-
Franciscan B15 mins
- Dermatology
Company Description: NFlection is a clinical stage biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppres ... -
Franciscan D15 mins
- Reproductive/Sexual Health
Maipl has created an exceptionally potent small molecule prostaglandin PGF2α antagonist, MA-7107, that has exquisite selectivity, without interfering other essential prostaglandin functions. High leve ...
11:00 AM
-
Imperial Ballroom50 minsThe ability of bispecific antibodies and antibody drug conjugates to interact with two biologic binding sites at once creates major leverage for interfering with a disease mechanism intercellularly as ...
-
Franciscan D15 mins
- Pain Management
Sustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant on ... -
Franciscan C15 mins
- Oncology
LBL Biotec. Inc. is a spin-off company from National Cheng-kung University at Taiwan. The company focusses on the development of IL-20 antibody to treat several inflammation-associated diseases such a ... -
Franciscan B15 mins
- Dermatology
Company Description: Shaperon Inc. is a clinical stage biotech company (KOSDAQ Ticker: 378800). It has 3 clinical stage assets. (1) Atopic Dermatitis: US FDA IND approval in September 2023. With its e ...
11:15 AM
-
Franciscan D15 mins
- Pain Management
South Rampart Pharma, Inc. is a clinical-stage biotech company focused on addressing the critical need for a safe and effective approach to relieving pain. Its lead clinical candidate, SRP-001, is a n ... -
Franciscan C15 mins
- Oncology
Multimeric Biotherapeutics, Inc. is an early-stage, founder-backed company focused on stimulating immunity against cancer and infections. Its patented FortiVac technology elicits very strong CD8+ T ce ... -
Franciscan B15 mins
- Gastrointestinal
Company Description: First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Fi ...
11:30 AM
-
Franciscan C15 mins
- Oncology
Enzyme by Design is a preclinical stage biotech startup specializing in engineering highly effective and significantly safer cancer biologics. -
Franciscan B15 mins
- Tools/Drug Development Support Tech
Company Description: GATC Health is an AI company transforming drug development and disease prediction. Our proprietary Multiomics Advanced Technology™ (MAT) simulates complex human physiology for the ... -
Franciscan D15 mins
- Pain Management
DIMERx is a platform company progressing an oral, non-addictive opioid analgesic for chronic pain through mid/late-stage clinical trials. DIMERx is developing DMX-101, a dimer of buprenorphine, for th ...
11:45 AM
-
Franciscan B15 mins
- Tools/Drug Development Support Tech
Company Description: Acoustic Bio is a Stanford University spin-out company focused on developing a platform to scale and accelerate screening of patient-derived organoids (PDOs) to advance personaliz ... -
Franciscan D15 mins
- Pain Management
Company Description: Rebel Medicine is a specialty pharmaceutical company headquartered in Salt Lake City, Utah, that leverages drug delivery science to create innovative therapies to address unmet me ... -
Franciscan C15 mins
- Oncology
Company Description: Orphagen is a pioneer in discovery and development of small molecule drugs that modulate orphan or unexplored members of the nuclear receptor family, one of the most successful dr ...
12:00 PM
-
60 mins
1:00 PM
-
Franciscan B/C/D240 minsAttend 13-minute presentations across several therapeutic areas.
-
Imperial Ballroom50 minsMore than 130 human health companies are in SOSV's portfolio, and more than 30 of those are pre-series-A biopharma start-ups in IndieBio's program. Mohan Iyer is a General Partner at SOSV’s IndieBio S ...
1:15 PM
-
Franciscan C15 mins
- Oncology
Kineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is ... -
Franciscan B15 mins
- Immunology
EYAM is a platform biotech company with strong animal efficacy data for an AI-informed self-amplifying RNA/DNA smart vector. We are seeking investment and strategic partnership opportunities. At Eyam, ... -
Franciscan D15 mins
- CNS/Neurological
OYE is a clinical stage pharmaceutical company focused on a late stage, low risk 505(b)2 opportunity that has already achieved market adoption and uptake in the hospital market.
1:30 PM
-
Franciscan B15 mins
- Infectious Diseases
Protalix is a commercial stage biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins that target rare genetic diseases with unmet m ... -
Franciscan D15 mins
- CNS/Neurological
Panorama Medicine is a world-leading drug developer in RNA splicing. Our AI-driven platform allows us to explore the vast, untapped RNA space for new modality discovery. We have built a pipeline with ... -
Franciscan C15 mins
- Oncology
Company Description: Cytovation is a clinical-stage immuno-oncology biotech focused on the development of CyPep-1, a first-in-class synthetic peptide that has been designed to selectively target cance ...
1:45 PM
-
Franciscan B15 mins
- Infectious Diseases
Company Description: Antisense Therapeutics Limited (ASX: ANP; OTC: ATHJY) is an Australian biotechnology company focused on rare diseases. Through a partnership with Ionis Pharmaceuticals (NASDAQ: IO ... -
Franciscan D15 mins
- CNS/Neurological
Company Description: Finding new therapies for brain diseases requires preclinical models and assays with increased clinical relevance. a:head aims to develop a human-based platform for generating com ... -
Franciscan C15 mins
- Oncology
Company Description: Yinuoke is a biotech company developing First-in-Concept therapies for cancer patients who have exhausted available therapies based on a deep and unique understanding of cancer bi ...
2:00 PM
-
Imperial Ballroom50 minsWith the majority of biological studies conducted in academic settings but nearly all innovative new drug clinical trials sponsored by industry, improving translational research success rates for comm ...
-
Franciscan C15 mins
- Oncology
Company Description: Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug D ... -
Franciscan D15 mins
- CNS/Neurological
Company Description: Jaya Biosciences (Jaya) is developing targeted gene therapies for impaired lysosome/autophagy function, a critical component in the etiology of severe neurodegenerative diseases, ... -
Franciscan B15 mins
- Infectious Diseases
Company Description: RS BioTherapeutics (RSBT) is developing a pharmaceutical compound for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other diseases characterized by pulmonary inflammati ...
2:15 PM
-
Franciscan B15 mins
- Infectious Diseases
Lactiga is an award-winning, visionary biotechnology company committed to pushing the boundaries of medical science and improving the lives of immunodeficient patients through innovative mucosal thera ... -
Franciscan C15 mins
- Oncology
Company Description: Welton Pharma is pre-clinical company developing our lead asset WP-038 for the treatment of colorectal cancer. Our patent-protected drug product is expected to increase the respon ... -
Franciscan D15 mins
- CNS/Neurological
Company Description: Ilios Therapeutics is a biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases. Our innovative c ...
2:30 PM
-
Franciscan B15 mins
- Infectious Diseases
Sarcomatrix is a preclinical stage biopharma developing novel therapeutics and enabling technologies across multiple indications; starting with muscle wasting diseases and muscular dystrophies. -
Franciscan D15 mins
- CNS/Neurological
EpiVario Inc. is pioneering epigenetic therapeutic development to redefine treatment landscapes for neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, ... -
Franciscan C15 mins
- Oncology
Company Description: Amberstone Biosciences is developing a new class of paradigm-shifting, Tumor Microenvironment Activated ThErapeutic (“T-MATE”) antibodies and cytokines that can offer significantl ...
2:45 PM
-
Franciscan D15 mins
- CNS/Neurological
Clinical stage drug company engineering drug combinations to accelerate neuroplasticity (brain's capacity to rebuild, rewire, and repair). Target patients are those suffering brain injuries, deteriora ... -
Franciscan C15 mins
- Oncology
Company Description: VerImmune Inc (www.verimmune.com) is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases. VerImmune ... -
Franciscan B15 mins
- Oncology
Company Description: A multi-indication, radiosensitizing platform to increase the effectiveness of radiotherapy and immunotherapy.
3:00 PM
-
Franciscan D15 mins
- Platform for Therapeutics
Macrobiome Therapeutics Pty Ltd is a company harnessing the therapeutic potential of hookworms and other parasitic helminths to develop drugs for the treatment of chronic wounds and autoimmune and met ... -
Imperial Ballroom50 minsWithin the past five years, RNA technologies have demonstrated they can improve patients’ health by transforming gene expression and open a successful new frontier for infectious disease vaccine devel ...
-
Franciscan C15 mins
- Oncology
Company Description: Kernal Bio is a biotech company developing mRNA 2.0 immunotherapies. Kernal mines translatome data to discover cell-specific sequence features and design mRNAs that are selectivel ... -
Franciscan B15 mins
- Metabolic Diseases
Company Description: Mitotech Ltd is a UK-based clinical stage biotechnology company developing mitochondria targeted drugs for a variety of neurodegenerative and metabolic diseases such as Obesity, N ...
3:15 PM
-
Franciscan D15 mins
- Platform for Therapeutics
Algen is a platform therapeutics and drug discovery company using the world’s leading CRISPR and AI to uncover disease-driving RNA messages to find treatments for cancer, inflammation and other diseas ... -
Franciscan C15 mins
- Oncology
Company Description: Degron Therapeutics is a preclinical-stage biotech dedicated to the discovery and development of a new class of targeted protein degradation therapeutics – small molecule molecula ... -
Franciscan B15 mins
- Multiple Therapeutics
Company Description: Sonata Therapeutics is creating a new class of therapeutics called network medicines. These are the first therapeutics designed specifically to reprogram diseased cells in order t ...
3:30 PM
-
Franciscan C15 mins
- Oncology
Company Description: Each year, an investment of $50 to $60 billion is directed towards oncology clinical trials, only to face an alarming 90% failure rate. The elevated failure rate largely stems fro ... -
Franciscan D15 mins
- Platform for Therapeutics
Company Description: Aperture Therapeutics is a pre-clinical stage drug discovery company developing novel therapeutics to modulate neuroinflammation in age-related neurodegenerative disorders. The co ... -
Franciscan B15 mins
- Tools/Drug Development Support Tech
Company Description: Synvivia optimizes cells for gene therapy manufacturing. Our technology increases gene therapy yield and potency by 3-10X, with thousands of improvements in the pipeline. Our prod ...
3:45 PM
-
Franciscan C15 mins
- Oncology
Private pre-clinical Biotech developing novel small molecules for multiple solid tumors -
Franciscan B15 mins
- Multiple Therapeutics
Proven, clinical stage company discovering and developing first-in-class kinase inhibitors for diseases of the liver, kidney, and CNS. Lead program is phase 2-ready and will be evaluated in liver and/ ... -
Franciscan D15 mins
- Platform for Therapeutics
Company Description: Farcast's mission is to improve predictability in cancer treatment. Farcast's Human Tumor Microdynamics (hTMD) platform generates and mines“tumor response big data” by uniquely cu ...
4:00 PM
-
Imperial Ballroom50 minsA recent article noted that the APAC biotech market is estimated to expand at a rapid compound annual growth rate of 16.8 percent up to 2028. With some of the world’s most populous countries, the need ...
-
Franciscan C15 mins
- Oncology
Synlico Inc. envisions rewriting medicine by bringing causality to cellular biology. As an AI-powered drug discovery biotech company, our primary mission is to develop cutting-edge engineered T cell t ... -
Franciscan D15 mins
- Platform for Therapeutics
Company Description: Kapoose Creek Bio is a Canadian biotech company using AI technologies to uncover small molecule medicines from nature with unprecedented speed and scale. Our R&D efforts are suppo ... -
Franciscan B15 mins
- Multiple Therapeutics
Company Description: Inimmune is harnessing the human immune system to create next generation immunotherapeutics for the treatment of allergy, infectious disease, autoimmunity, opioid addiction and ca ...
4:15 PM
-
Franciscan D15 mins
- Platform for Therapeutics
Commercializing the human Trophoblast Stem Cell Platform for Cell and Gene Therapy -
Franciscan C15 mins
- Oncology
Company Description: YDS Pharmatech, Inc. is heading for next-generation induced-proximity drug discovery. Using our AI+biophysics simulation combined with proteomics technologies to advance the disco ... -
Franciscan B15 mins
- Multiple Therapeutics
Company Description: Caledon Bioscience is a newly formed, privately held, spin-out. We are a development stage biopharmaceutical company focused on discovering and developing novel and distinctive sm ...
5:30 PM
-
60 minsJoin your fellow attendees for a networking reception to close out Day 1. Take the elevator in Tower 1 to the 46th floor.
6:30 AM
-
570 mins
7:30 AM
-
510 mins
9:00 AM
-
Franciscan B/C/D180 minsAttend 13-minute presentations across several therapeutic areas.
9:15 AM
-
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: GelMEDIX is a seed-stage, Harvard/UCLA founded, cell therapy company focused on overcoming the fundamental challenges of current retinal cell therapy technologies to create vision ... -
Franciscan C15 mins
- Oncology
Company Description: Actym Therapeutics has engineered a new drug modality harnessing the power of a genetically modified bacterial vehicle that safely introduces therapeutic payloads to activate the ...
9:30 AM
-
Franciscan C15 mins
- Oncology
Allterum Therapeutics is a Fannin-founded biopharmaceutical company targeting the IL-7 pathway for the treatment of patients with Acute Lymphoblastic Leukemia (ALL) and other cancers expressing CD127 ... -
Franciscan B15 mins
- CNS/Neurological
Company Description: LEVERaging RNA regulatory mechanisms to drug the undruggable with RNA-targeted therapeutics. We identify novel target RNA biology and design targeted therapeutics to increase, inh ... -
Franciscan D15 mins
- Infectious Diseases
Company Description: A preclinical stage biotech company in anti-infectives space, developing safer and efficacious biologics therapies against serious invasive fungal infections. Supported by a propr ...
9:45 AM
-
Franciscan C15 mins
- Oncology
Pinetree Therapeutics is a biotechnology developing novel medicines to combat drug resistance in oncology and beyond. Pinetree's platform technology AbReptor™ is a first and best-in-class, transformat ... -
Franciscan D15 mins
- Regenerative Medicine
Company Description: Spry Bio, Inc. is a pre-clinical biotechnology company developing Optimized Platelet Therapies (OPTs) for treating osteoarthritis (OA) and other medical conditions characterized b ... -
Franciscan B15 mins
- Oncology
Company Description: We are a biotech company that has been developing new drugs by focusing on the protein degrader field since 2016/2017. About 50 people are working together in Korea, the United St ...
10:00 AM
-
Franciscan D15 mins
- Ophthalmology
ViAn Therapeutics is developing an antiangiogenic peptidic drug for topical application in high-impact retinal diseases (DR, DME, AMD). Besides the non-invasive administration, this drug can stabilize ... -
Imperial Ballroom50 minsSince the passage of the Inflation Reduction Act, companies, investors, and patients have raised concerns about how the legislation will impact innovation in the biotech industry. Will there be a decl ...
-
Franciscan C15 mins
- Oncology
Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and development of novel oncology drugs that target the DNA damage response (DDR) in cancer cells. -
Franciscan B15 mins
- CNS/Neurological
Company Description: Monument Tx is a clinical stage neuroscience-specialist drug development company. Taking our cue from oncology, we aim to radically reduce drug development timeframes, and increas ...
10:15 AM
-
Franciscan D15 mins
- Ophthalmology
Drusolv Therapeutics is a clinical-stage drug company based in Philadelphia. We are repurposing oral atorvastatin (using a novel formulation) for the new indication of early intervention in age-relate ... -
Franciscan B15 mins
- CNS/Neurological
Scioto Biosciences leverages discovery to improve lives. Good bacteria in our bodies have the potential to promote health and treat disease. Science suggests now that many disorders previously not con ... -
Franciscan C15 mins
- Oncology
Mobilizing endogenous bi-specific Natural-Killer T-like cells that penetrate solid tumors and blood cancers
10:30 AM
-
Franciscan C15 mins
- Oncology
Bexion is a clinical stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy. The Company’s lead ass ... -
Franciscan D15 mins
- Ophthalmology
Caeregen is a breakthrough regenerative medicine therapeutics company targeting neurosensory diseases, with a revolutionary first drug, CTR-107 (Noregen), for vision loss and blindness from retinal d ... -
Franciscan B15 mins
- CNS/Neurological
Company Description: Aruna’s AB126, a therapeutic exosome, is an innovative neural anti-inflammatory and neuromodulator that naturally crosses the blood-brain-barrier. Using exosomes from neural stem ...
10:45 AM
-
Franciscan B15 mins
- Gene/Cell Therapy
Aegle Therapeutics is a clinical stage biotech company with a platform technology focused on rare diseases. Aegle first product, AGLE-102, is a compositive of nanoparticles called extracellular vesicl ... -
Franciscan C15 mins
- Oncology
Biofidelity is a rapidly-growing commercial-stage genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world. ASPYRE®, the first application of ou ... -
Franciscan D15 mins
- Ophthalmology
Epion Therapeutics (Epion) is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart™, its transformativ ...
11:00 AM
-
Franciscan B15 mins
- Gene/Cell Therapy
Coastar Therapeutics is a San Diego based company focusing on systemic gene delivery technology. The company has developed a novel ENHEnS technology that can coat human cell membrane on each individua ... -
Imperial Ballroom50 minsA Nature biotechnology report cited an analysis of the 25 most active VC firms that shows less than 1% of senior level investment teams have partners from underrepresented racial and ethnic groups. Mc ...
-
Franciscan D15 mins
- Respiratory
Advagene is a discovery company focuses on immunotherapy and intranasal vaccine for respiratory hypersensitivity and infection. The LTh(αK), intellectual property owned by Advagene, is developed by th ... -
Franciscan C15 mins
- Oncology
Company Description: Cellworks Group, Inc. is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients an ...
11:15 AM
-
Franciscan B15 mins
- Gene/Cell Therapy
The mission of CDR3 is to develop a curative stem cell gene immunotherapy, delivering chimeric antigen receptors (CARs) or T cell receptors (TCRs) to treat chronic viral infections and virus-associate ... -
Franciscan D15 mins
- Respiratory
Inhalon Biopharma is a clinical-stage biotechnology company developing faster-acting, more effective, self-administered inhaled treatments to address the over $40B worldwide unmet need for patients su ... -
Franciscan C15 mins
- Oncology
Rakuten Medical is a private biotechnology firm that is developing cancer therapies with the ability to target cancer cells and induce immunogenic cell death, using a photoimmunotherapy platform with ...
11:30 AM
-
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: Celosia Therapeutics is a late discovery / early pre-clinical phase gene therapy company that is changing the paradigm for treatment for neurodegenerative disease. This is achieve ... -
Franciscan D15 mins
- Respiratory
Company Description: Donovan B. Yeates, Ph.D., Founder and CEO, KAER Biotherapeutics Corporation is introducing a two new game-changing product line, AeroPulsR. This device enables aqueous liquid surf ... -
Franciscan C15 mins
- Oncology
Company Description: Tundra Targeted Therapeutics develops bispecific antibodies to treat difficult cancers. The lead candidate targets leukemia and lymphoma by harnessing and activating a patient’s o ...
11:45 AM
-
Franciscan C15 mins
- Oncology
Jaguar Health is a commercial stage pharmaceuticals company that develops novel, plant-based, sustainably derived prescription medicines for GI distress. Our Mytesi® (crofelemer) product (tablet) is F ... -
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: OmniSpirant was founded by Mr Gerry McCauley, a pharmacist, and inventor of the first-in-class inhaled regenerative gene therapy platform technology (OmniSomes). OmniSpirant ident ... -
Franciscan D15 mins
- Cardiovascular
Company Description: KaloCyte is a pre-clinical biotech therapeutic startup company developing ErythroMer, a bioengineered artificial red blood cell (RBC) substitute that can be freeze-dried for long- ...
12:00 PM
-
Imperial Ballroom50 minsDr. Julia Owens is an experienced biopharmaceutical CEO and board member with a deep commitment to advancing innovative therapies for patients over a 20+ year professional career. She brings a unique ...
-
60 mins
1:00 PM
-
Franciscan B/C/D240 minsAttend 13-minute presentations across several therapeutic areas.
-
Imperial Ballroom50 minsRelative to other highly prevalent diseases such as cancers or cardiovascular disease, companies seeking therapies for neurodegeneration have struggled with drug delivery and biomarker validation insi ...
1:15 PM
-
Franciscan B15 mins
- Metabolic Diseases
Zucara Therapeutics Inc. is developing ZT-01, a first-in-class therapeutic to prevent insulin-induced hypoglycemia (low blood sugar) in patients using insulin therapy. ZT-01 is designed to inhibit som ... -
Franciscan C15 mins
- Infectious Diseases
Company Description: Company Name: AMR Therapeutics (AMRTx) Company Description: AMRTx is a pioneering biotechnology firm. We are dedicated to revolutionizing post-antibiotics patient care by developi ...
1:30 PM
-
Franciscan C15 mins
- Infectious Diseases
Blue Lake Biotechnology is re-inventing vaccines with a next generation intranasal vaccine vector. Our plug-and-play platform produces vaccines that generate a full spectrum of immune responses to pro ... -
Franciscan B15 mins
- Metabolic Diseases
Company Description: Adge Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of best-in-class therapies for the management of obesity and metabolic syndrome. Adge ...
1:45 PM
-
Franciscan C15 mins
- Infectious Diseases
Aeolian Biotech Corp is committed to creating an improved, next generation pneumococcal conjugate vaccine (iPCV22) that is designed to provide best in class coverage for adults. -
Franciscan B15 mins
- Metabolic Diseases
Company Description: Glyscend Therapeutics is a clinical-stage biopharmaceutical company that is reshaping the treatment of metabolic disease with first-in-class oral polymeric drugs that have the pot ...
2:00 PM
-
Imperial Ballroom50 minsLast year, Google’s AlphaFold project demonstrated it can model more than 200 million molecular 3-D structures, including nearly all known proteins, by applying computational biology and artificial in ...
-
Franciscan C15 mins
- Infectious Diseases
Company Description: Baiya Phytopharm Co., Ltd. (Baiya Phytopharm) commenced as a spin off in Bangkok, Thailand in 2018 to a global, clinical phase biopharmaceutical company in 2021. We specialize in ...
2:15 PM
-
Franciscan B15 mins
- Gene/Cell Therapy
Garuda Therapeutics seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewin ... -
Franciscan C15 mins
- Infectious Diseases
Company Description: Vaxess is an RA Capital-backed, clinical-stage company bringing healthcare out of the clinic with the MIMIX Smart Release patch platform. The MIMIX platform, developed at MIT, use ...
2:30 PM
-
Franciscan C15 mins
- Inflammation
Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for patients suffering from chronic inflammatory diseases. We are a group ... -
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: XyloCor Therapeutics, Inc. is a private, clinical stage biopharmaceutical company developing potential best in class gene therapies to transform outcomes for patients with cardiov ...
2:45 PM
-
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: Carina Biotech is a private Australian immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T t ... -
Franciscan C15 mins
- Inflammation
Company Description: Serpass Biologics is a Biotech start up established at Arizona State University, Biodesign Inst. We are developing virus-derived immune and coagulation modulating proteins, a new ...
3:00 PM
-
Imperial Ballroom50 minsAfter an 80% decline in IPO volume from the 2021 peak and the Federal Reserve’s start of raising interest rates, conditions appear now to be shifting towards stabilizing rates and slowly opening the I ...
-
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: Neomics is a cell and gene therapy company innovating adoptive cell therapy to cure cancers and mcDNA to usher new era of genetic medicines. NPB5005-V283 Novel effective anti-BCMA ...
3:15 PM
-
Franciscan B15 mins
- Gene/Cell Therapy
Company Description: CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on human immunodiagnostic and autologous anticancer vaccines, devel ...
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)